Creo Medical Financials
| CREO Stock | 13.13 0.25 1.94% |
Creo |
Understanding current and past Creo Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Creo Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Creo Medical's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Creo Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Creo Medical Group. Check Creo Medical's Beneish M Score to see the likelihood of Creo Medical's management manipulating its earnings.
Specialization | Health Care, Health Care Equipment & Services |
| Instrument | UK Stock View All |
| Exchange | London Exchange |
| ISIN | GB00BZ1BLL44 |
| Business Address | Creo House, Chepstow, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.creomedical.com |
| Phone | 44 12 9160 6005 |
You should never invest in Creo Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Creo Stock, because this is throwing your money away. Analyzing the key information contained in Creo Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Creo Medical Key Financial Ratios
There are many critical financial ratios that Creo Medical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Creo Medical Group reports annually and quarterly.| Return On Equity | -0.38 | ||||
| Return On Asset | -0.2 | ||||
| Target Price | 71.33 | ||||
| Number Of Employees | 278 | ||||
| Beta | 0.82 |
Creo Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Creo Medical's current stock value. Our valuation model uses many indicators to compare Creo Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Creo Medical competition to find correlations between indicators driving Creo Medical's intrinsic value. More Info.Creo Medical Group is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Creo Medical's earnings, one of the primary drivers of an investment's value.Creo Medical Group Systematic Risk
Creo Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Creo Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Creo Medical Group correlated with the market. If Beta is less than 0 Creo Medical generally moves in the opposite direction as compared to the market. If Creo Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Creo Medical Group is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Creo Medical is generally in the same direction as the market. If Beta > 1 Creo Medical moves generally in the same direction as, but more than the movement of the benchmark.
Creo Medical Thematic Clasifications
Creo Medical Group is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Creo Medical March 23, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Creo Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Creo Medical Group. We use our internally-developed statistical techniques to arrive at the intrinsic value of Creo Medical Group based on widely used predictive technical indicators. In general, we focus on analyzing Creo Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Creo Medical's daily price indicators and compare them against related drivers.
| Information Ratio | (0.19) | |||
| Maximum Drawdown | 14.89 | |||
| Value At Risk | (5.00) | |||
| Potential Upside | 3.35 |
Additional Tools for Creo Stock Analysis
When running Creo Medical's price analysis, check to measure Creo Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creo Medical is operating at the current time. Most of Creo Medical's value examination focuses on studying past and present price action to predict the probability of Creo Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creo Medical's price. Additionally, you may evaluate how the addition of Creo Medical to your portfolios can decrease your overall portfolio volatility.